Benazepril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
{{Benazepril}} | |||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{AM}}, {{AZ}} | |||
{{CMG}}; {{AE}} {{AM}} | |||
'''''For patient information about Benazepril, click [[Benazepril (patient information)|here]].''''' | '''''For patient information about Benazepril, click [[Benazepril (patient information)|here]].''''' |
Revision as of 17:46, 24 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]
For patient information about Benazepril, click here.
Synonyms / Brand Names: Lotensin®
Overview
Benazepril, brand name Lotensin (Novartis), is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.
Category
Ace-inhibitors